Aethlon Medical, Inc (AEMD)

Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Vir Biotech Shuns FDA ...

In this article, we will look at 10 healthcare and biotech stocks to buy amid the monkeypox threat. If you want to explore similar healthcare and biotech stocks, you can also take a look at 5 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat. In May of 2022, the first case of the monkeypox […]

Gainers T2 Biosystems (NASDAQ:TTOO) shares increased by 15.45% to $0.14. The company's market cap stands ...

Aethlon Medical Inc(NASDAQ: AEMD)said it is commissioninga newin vitrobinding experiment to confirm ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for another dive into the biggest pre-market stock movers as we check out the latest news for Wednesday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt ...

Aethlon Medical (NASDAQ:AEMD) reported its Q1 earnings results on Tuesday, August 9, 2022 at 04:15 PM. Here's what ...

Gainers Rockwell Medical (NASDAQ:RMTI) shares increased by 16.6% to $1.83 during Tuesday's after-market session. The ...

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial results for its first quarter ended June 30, 2022 and provided an update on recent developments.

Gainers Karuna Therapeutics (NASDAQ:KRTX) shares increased by 63.5% to $229.46 during Monday's regular session. As ...

Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) stock increased by 18.0% to $39.49 during Monday's pre-market ...

The Biden administration has officially declared monkeypox a public health emergency as cases continue to rise in the U.S., ...

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its first quarter ended June 30, 2022, at 4:15 p.m. EST on Tuesday, August 9, 2022.

Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese ...

On Monday, shares of Aethlon Medical, Inc. (NASDAQ: AEMD) experienced volatile short activity. After the activity, the stock price went ...

Gainers AMTD IDEA Group (NYSE: AMTD) rose 217.3% to $6.60 in pre-market trading after jumping 18% on Monday. The company owns 90%+ ...

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around ...

Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter ...

The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We're starting off Monday with a breakdown of the biggest pre-market stock movers traders will want to watch! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” Cash Holders Could Get Hit Hard THIS FRIDAY

Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company ...

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced the publication of a peer-reviewed journal article in PLOS ONE. The article, titled "Removal of Clinically Relevant SARS-CoV-2 Variants by An Affinity Resin Containing Galanthus nivalis Agglutinin," contains data demonstrating that the proprietary GNA affinity resin of the Aethlon Hemopurifier® efficiently captur

Reutersreported thatthe U.S. Centers for Disease Control and Prevention (CDC) plans to make monkeypox infection a ...

The U.S. Food and Drug Administration (FDA) has approved an amendment to the protocol of the ongoing clinical trial investigating ...

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved an amendment to the protocol of its ongoing clinical trial investigating the Aethlon Hemopurifier® for patients with severe COVID-19. The newly approved protocol amendment eliminates the inclusion criteria that patients must have a dialysis catheter in

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. ...

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation ...

By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Expanding the Potential Indications for Hemopurifier Treatment Aethlon Medical’s (NASDAQ:AEMD) clinical trials are moving forward and expanding, as AEMD continues to demonstrate the effectiveness of its lead product, the Aethlon Hemopurifier®, in a broad range of viruses and conditions in single patient emergency use cases and in in vitro

Aethlon Medical (NASDAQ:AEMD) brought in sales totaling $13.12 thousand during Q4 according to data provided by Benzinga Pro. However, ...